Department of General Medicine, National Defense Medical College, Tokorozawa, Japan.
Department of Cardiovascular Medicine, Toho University, Tokyo, Japan.
Ann Noninvasive Electrocardiol. 2022 Mar;27(2):e12923. doi: 10.1111/anec.12923. Epub 2021 Dec 6.
Noninvasive electrocardiographic markers (NIEMs) are promising arrhythmic risk stratification tools for assessing the risk of sudden cardiac death. However, little is known about their utility in patients with chronic kidney disease (CKD) and organic heart disease. This study aimed to determine whether NIEMs can predict cardiac events in patients with CKD and structural heart disease (CKD-SHD).
We prospectively analyzed 183 CKD-SHD patients (median age, 69 years [interquartile range, 61-77 years]) who underwent 24-h ambulatory electrocardiographic monitoring and assessed the worst values for ambulatory-based late potentials (w-LPs), heart rate turbulence, and nonsustained ventricular tachycardia (NSVT). The primary endpoint was the occurrence of documented lethal ventricular tachyarrhythmias (ventricular fibrillation or sustained ventricular tachycardia) or cardiac death. The secondary endpoint was admission for cardiovascular causes.
Thirteen patients reached the primary endpoint during a follow-up period of 24 ± 11 months. Cox univariate regression analysis showed that existence of w-LPs (hazard ratio [HR] = 6.04, 95% confidence interval [CI]: 1.4-22.3, p = .007) and NSVT [HR = 8.72, 95% CI: 2.8-26.5: p < .001] was significantly associated with the primary endpoint. Kaplan-Meier analysis demonstrated that the combination of w-LPs and NSVT resulted in a lower event-free survival rate than did other NIEMs (p < .0001). No NIEM was useful in predicting the secondary endpoint, although the left ventricular mass index was correlated with the secondary endpoint.
The combination of w-LPs and NSVT was a significant risk factor for lethal ventricular tachyarrhythmias and cardiac death in CKD-SHD patients.
非侵入性心电图标志物(NIEMs)是评估心源性猝死风险的有前途的心律失常风险分层工具。然而,对于患有慢性肾脏病(CKD)和器质性心脏病的患者,其应用知之甚少。本研究旨在确定 NIEMs 是否可预测 CKD 合并结构性心脏病(CKD-SHD)患者的心脏事件。
我们前瞻性分析了 183 例 CKD-SHD 患者(中位年龄,69 岁[四分位间距,61-77 岁]),这些患者接受了 24 小时动态心电图监测,并评估了基于动态心电图的晚期电位(w-LPs)、心率震荡和非持续性室性心动过速(NSVT)的最差值。主要终点是记录到致命性室性心律失常(室颤或持续性室性心动过速)或心脏性死亡的发生。次要终点是心血管原因入院。
在 24 ± 11 个月的随访期间,13 例患者达到了主要终点。Cox 单因素回归分析显示,w-LPs 的存在(危险比[HR] = 6.04,95%置信区间[CI]:1.4-22.3,p =.007)和 NSVT(HR = 8.72,95%CI:2.8-26.5:p <.001)与主要终点显著相关。Kaplan-Meier 分析表明,w-LPs 和 NSVT 的组合导致的无事件生存率低于其他 NIEMs(p <.0001)。虽然左心室质量指数与次要终点相关,但没有 NIEM 可用于预测次要终点。
w-LPs 和 NSVT 的组合是 CKD-SHD 患者发生致命性室性心律失常和心脏性死亡的显著危险因素。